• The Latest Updated Products
  • Home > Product Partnering > The Latest Updated Products
Basic Search Search

Displaying 1 of 21 results per page Prev Next

The Latest Updated Products 게시물 리스트
product_code originator Lab Code or BRAND NAME API Action mechanism Indication Latest development stage Details
 PP090113005630   Traws Pharma, Inc.(since Apr 2024), Onconova Therapeutics Inc.   Estybon IV, ON01910-Na   rigosertib sodium   A polo-lik..   2nd line h..   Phase III, Preclinical completed, Preclinical completed    View Details 
 PP090113005631   Traws Pharma, Inc.(since Apr 2024), Onconova Therapeutics Inc.   Estybon Oral, ON01910-Na   rigosertib sodium   A polo-lik..   1st line l..   Phase II, Phase II, Preclinical completed, Preclinical completed    View Details 
 PP120713009948   Traws Pharma, Inc.(since Apr 2024), Onconova Therapeutics Inc.   ON123300, HX301   narazaciclib   A dual inh..   Metastatic..   Phase II, Phase II    View Details 
 PP121205010545   TME Pharma (since Jul 2022), NOXXON Pharma   NOX-E36   emapticap pegol   Neutralizi..   Diabetic n..   Phase II, Phase II, Preclinical completed, Phase I    View Details 
 PP121205010546   TME Pharma (since Jul 2022), NOXXON Pharma   NOX-A12   olaptesed pegol   Targeting ..   Glioblasto..   Phase II, Phase II, Phase II, Phase II, Phase II    View Details 
 PP130509011219   Trevena, Inc.   TRV734      A Mu opioi..   Opioid use..   Phase I    View Details 
 PP130509011220   Trevena, Inc.   TRV250 Oral      A delta op..   Acute migr..   Phase I    View Details 
 PP130731011656   Zydus Therapeutics   Lipaglyn   saroglitazar Mg   A dual, pe..   Hypertrigl..   Approved, Approved, Phase III, Approved, Approved, NDA    View Details 
 PP130802011690   Grunenthal GmbH   GRT6005, TRN-228, PRK-101   cebranopadol   A full ago..   Acute pain..   Phase III completed, Phase II, Phase II, Preclinical completed    View Details 
 PP130930011933   Shinpoong Pharm. Co., Ltd   SP-8203   otaplimastat   Inhibition..   Acute isch..   Phase III, Phase I    View Details